ArticleHuman vaccines & immunotherapeutics2015

Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country.

Giannina Izquierdo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.